Adult Burkitt's Lymphoma: Clinical and Prognostic Evaluation of 20 Patients

References

• Burkitt D. A sarcoma involving the jaws in African children. Br. J. Surg. 1958; 46: 218–221
   PubMed Web of Science ®Google Scholar
• Levine P. H., Cho B. R., Connelley R. R., et al. The American lymphoma registry: A progress report. Ann. Intern. Med. 1975; 83: 31–36
   PubMed Web of Science ®Google Scholar
• Grogan T. M., Wamke R. A., Kaplan H. S. A comparative study of Burkitt's and non-Burkitt's “undifferentiated” malignant lymphoma: Immunologic, cytochemical, ultrastructural, cytologic, histopathologic, clinical and cell culture features. Cancer 1982; 49: 1817–1828
   PubMed Web of Science ®Google Scholar
• Levine A. M., Pavlova Z., Pockros A. W. Small noncleaved follicular center cell (FCC) lymphoma: Burkitt's and non-Burkitt's variants in the United States. I. Clinical features. Cancer 1983; 52: 1073–1079
   PubMed Web of Science ®Google Scholar
• Berard C. W., O'Connor G. T., Thomas L. B., et al. Histopathological definition of Burkitt's tumor. Bull. WHO 1969; 40: 601–607
   PubMed Web of Science ®Google Scholar
• Klein G. The Epstein-Barr virus and neoplasia. N. Engl. J. Med. 1973; 293: 1353–1355
   Web of Science ®Google Scholar
• The Fifth International Workshop on Chromosomes in Leu-kemia-Lymphoma: Correlation of chromosome abnormalities with histologic and immunologic characteristics in non-Hodg-kin's lymphoma and adult T cell leukemia-lymphoma. Blood 1987; 70: 1554–1564
   PubMed Web of Science ®Google Scholar
• Pelicci P. G., Knowles D. M., Magrath I., et al. Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc. Natl. Acad. Sci. USA 1986; 83: 2984–2988
   PubMed Web of Science ®Google Scholar
• Neri A., Barriga F., Knowles D. M., et al. Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenic forms of Burkitt lymphoma. Proc. Natl. Acad. Sci. USA 1988; 85: 2748–2752
   PubMed Web of Science ®Google Scholar
• Lennert K., Mohri N. Histopathology and Diagnosis of non-Hodgkin's Lymphomas. Malignant Lymphomas Other Than Hodgkin's Disease: Histology, Cytology, Ultrastructure, Immunology, Lennert K, K Lennert. Springer-Verlag, Berlin 1978; 111–169
   Google Scholar
• Bernstein J. I., Coleman C. N., Strickler J. C., Dorfman R. F., Rosenberg S. A. Combined modaling therapy for adults with small non-cleaved cell lymphoma (Burkitt's and Burkitt's types). J. Clin. Oncol. 1986; 4: 847–858
   PubMed Web of Science ®Google Scholar
• Arsenau J. C., Canellos G. P., Banks P. M., Berard C. W., Granlick A. R., De Vita V. T. American Burkitt's lymphoma: Clinicopathologic study of 30 cases. Am. J. Med. 1975; 58: 314–321
   PubMed Web of Science ®Google Scholar
• Bemasconi C., Brusamolino E., Pagnucco G., Bernasconi P., Orlandi E., Lazzarino M. Burkitt's lym-phoma/leukemia: a clinicopathologic study on 24 adult patients. Leukemia 1991; 5: 90–94
   Web of Science ®Google Scholar
• Straus D. J., Wong G. Y., Lin J., et al. Small non cleaved-cell lymphoma (undifferentiated lymphoma Burkitt's type) in american adults. Results with treatment designed for acute lymphoblastic leukemia. Am. J. Med. 1991; 90: 328–337
   PubMed Web of Science ®Google Scholar
• Lopez T. M., Hagemeister F. B., Mc Laughlin P., et al. Small non-cleaved cell lymphoma in adults. Superior results for stages I-II disease. J. Clin. Oncol. 1990; 8: 615–622
   PubMed Web of Science ®Google Scholar
• Murphy S. B., Bowman W. P., Abramovitch M., et al. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J. Clin. Oncol. 1986; 4: 1732–1739
   PubMed Web of Science ®Google Scholar
• Mazza P., Bertini M., Mazza P., et al. Lymphoblastic Lymphoma in Adolescents and Adults. Clinical, Pathological and Prognostic Evaluation. Eur. J. Cancer Clin. Oncol. 1986; 21: 1503–1510
   Google Scholar
• Magrath I., Lee Y. J., Anderson T., et al. Prognostic factors in Burkitt's lymphoma. Importance of total tumor burden. Cancer 1980; 45: 1507–1515
   PubMed Web of Science ®Google Scholar
• Magrath I. T., Janus C., Edwards B. K., et al. An effective therapy for both undifferentiated (including Burk-itt's) lymphomas and lymphoblastic lymphomas in children and young adults. Blood 1984; 63: 1102–1111
   PubMed Web of Science ®Google Scholar
• Ziegler J. L. Treatment results of 54 patients with Burkitt's lymphoma are similar to the African experience. N. Engl. J. Med. 1977; 297: 7580–7584
   Web of Science ®Google Scholar
• Tura S., Mazza P., Lauria F., et al. Non-Hodgkin's lymphomas in leukaemic phase: incidence, prognosis and therapeutic implications. Scand. J. Haematol. 1985; 35: 123–131
   PubMedGoogle Scholar
• Murphy S. B., Fairclough D. L., Hutchinson R. E., Berard C. W. Non-Hodgkin's lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases in a single institution. J. Clin. Oncol. 1989; 7: 186–193
   PubMed Web of Science ®Google Scholar
• Carbone P. P., Kaplan H. S., Musshoff K. Report of Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971; 31: 1860–1861
   PubMed Web of Science ®Google Scholar
• Wollner N., Exelby P. R., Lieberman P. H. Non-Hodgkin's lymphoma in children. A progress report on the original patients treated with LSA2-L2 protocol. Cancer 1979; 44: 1990–1999
   PubMed Web of Science ®Google Scholar
• Guglielmi C., Amadori S., Anselmo A. P., et al. Sequential chemotherapy of high-grade non-Hodgkin's lymphoma with 5-fluorouracil, methotrexate, cytosine-arabino-side, cyclophosphamide, doxorubicin, vincristine and prednisone (F-MACHOP). Cancer Invest. 1987; 5: 159–169
   PubMed Web of Science ®Google Scholar
• Klimo P., Connors J. M. MACOP-B chemotherapy for the treatment of the diffuse large-cell lymphoma. Ann. Intern. Med. 1985; 102: 190–195
   Google Scholar
• Kaplan E. L., Meier P. Non-parametric estimation from incomplete observations. J. Am. Stat. Assoc 1958; 53: 457–481
   Web of Science ®Google Scholar
• Bouffet E., Frappaz D., Pinkerton R., Favrot M., Philip T. Burkitt's lymphoma: a model for clinical oncology. Eur. J. Cancer 1991; 27: 504–509
   PubMed Web of Science ®Google Scholar
• Philip T., Meckenstock R., Deconnick E., et al. Treatment of poor prognosis Burkitt's lymphoma in adults with the Societe Francaise d'Oncologie Pediatrique LMB Protocol-a study of the Federation Nationale des Centres de Lutte Contre le Cancer (FNLCC). Eur. J. Cancer 1992; 28A: 1954–1959
   PubMed Web of Science ®Google Scholar